[Federal Register: November 29, 2002 (Volume 67, Number 230)]
[Notices]
[Page 71184]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29no02-102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Innovative Approaches for Combating
Antimicrobial Resistance.
Date: December 16-18, 2002.
Time: 8:30 am to 6:00 PM.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Alec Ritchie, PhD, Scientific Review
Administrator, National Institute of Allergy and Infectious
Diseases, 6700 B Rockledge Drive, MSC 7616, Room 2223, Bethesda, MD
20892-7616, 301-435-1614, ar266w@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 21, 2002.
LaVerne Y. Sringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-30239 Filed 11-27-02; 8:45 am]
BILLING CODE 4140-01-M